Theresa A. Deisher, Ph.D.
CEO and CSO
Doctoral degree in Molecular and Cellular Biology from Stanford University School of Medicine. Holds more than 47 issued US/EU/Japan patents and 3 discoveries in clinical trials. Over 30 years of pharmaceutical leadership experience including Genentech, Repligen, ZymoGenetics, Immunex, and Amgen.
Location
Seattle, United States
Previous companies
